Last reviewed · How we verify

NCT04244526

Urinary Tract Infection in Pregnancy

Status unknown Last updated 30 January 2020
What this trial tests

trial testing Talking a urine sample in Urinary Tract Infections in 155 participants. Status unknown.

Timeline
1 March 2020
Primary endpoint
1 March 2021
1 May 2021

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment155
Start date1 March 2020
Primary completion1 March 2021
Estimated completion1 May 2021

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 45, female only, with Urinary Tract Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* to describe the profile of uropathogenic E coli from Egyptian pregnant women with UTIs and a symptomatic bacteriuria. * to determine the susceptibility pattern of our local isolated UPEC strains which is essential for optimal management of UTI. * to evaluate the different virulence genes in UPEC isolates and their association with antibiotic resistance. * to track common UPEC serogroups. * to investigate the biofilm formation and the relationship between virulence genes and biofilm formation in UPEC strains isolated from patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Urinary Tract Infections

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04244526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing